13. Knowledge
translation-KT
Knowledge translation (KT) is the
umbrella term for all of the activities
involved in moving research from the
laboratory, the research journal, and the
academic conference into the hands of
people and organizations who can put it
to practical use
14. Canadian Institutes for Health Research (CIHR)
“Knowledge translation (KT) is
defined as a dynamic and iterative
process that includes synthesis,
dissemination, exchange and
ethically-sound application of
knowledge to improve the health of
Canadians, provide more effective
health services and products and
strengthen the health care system”
15.
16.
17. Evidence Based
Medicine
Evidence based
medicine is the
judicious and
conscientious use of the
best evidence from
research, combined with
clinical experience,
and applied to patient
problems.
25. The case
A 65 year old male with a long history of type 2
diabetes and obesity.
Otherwise his medical history is unremarkable. He
does not smoke.
He had knee surgery 10 years ago but otherwise has
had no other major medical problems.
Over the years he has tried numerous diets and
exercise programs to reduce his weight but has not
been very successful.
26. The case
His granddaughter just started high school and he
wants to see her graduate and go on to college.
He understands that his diabetes puts him at a high
risk for heart disease and is frustrated that he
cannot lose the necessary weight.
His neighbor told him about a colleague at work
who had his stomach stapled and as a result not
only lost over 100 lbs. but also "cured" his diabetes.
He wants to know if this procedure really works.
27. PICO is a mnemonic that helps
one remember the key components
of a well focused question
P-Patient problem
I-
Intervention,Progn
ostic or Exposure
C-Comparison
O-Outcome
33. Evidence resources
There are literally
millions of
published reports,
journal articles,
correspondence
and studies
available to
clinicians
34. Evidence sources
Primary resources: PubMed/MEDLINE will give you access to
the primary literature.
Secondary resources: ACP Journal Club, Essential Evidence,
FPIN Clinical Inquiries, and Clinical Evidence will provide
you with an assessment of the original study.
The Cochrane Library provides access to systematic reviews
which help summarize the results from a number of studies.
These are often called “pre-appraised” or EBP resources.
46. Evaluating the Validity
of a Therapy Study
Three basic questions that need to be
answered for every type of study:
Are the results of the study valid?
What are the results?
Will the results help in caring for my
patient?
47. Evaluating
Medical Research
• look for certain criteria to
determine the research quality.
– Know what questions to answer.
• Read every part of the
research.
• Consider the type of journal
48. Evaluating Medical Research
• Peer review helps ensure
quality.
– Subject-matter experts
review material prior to
publication
• Internet sites can be
valid tools.
• Studies must follow a
structured process.
• There will always be
limitations.
49. Validity criteria.
1. Were patients randomized?
2. Was group allocation concealed?
3. Were patients in the study groups
similar with respect to known
prognostic variables?
Guyatt, G. Rennie, D. Meade, MO, Cook, DJ. Users' Guide to Medical Literature: A
Manual for Evidence-Based Clinical Practice, 2nd Edition 2008.
50. Validity criteria.
4. To what extent was the study blinded?
5. Was follow-up complete?
6. Were patients analyzed in the groups
to which they were first allocated?
7. Aside from the experimental
intervention, were the groups treated
equally?
51. next step is to
review the results.
How large was the treatment effect?
What was the absolute risk
reduction?
54. Absolute Benefit
Increase (ABI)
The arithmetic difference between the rates of
events in the experimental and control group
An Absolute Benefit Increase (ABI) refers to
the increase of a good event as a result of
the intervention.
An Absolute Risk Reduction (ARR) refers to
the decrease of a bed event as the result of
the intervention. [ARR = EER-CER]
55. Relative Risk (RR)
the ratio of the risk in the
experimental group compared to the
risk in the control group.
Proportional reduction in risk between
the rates of events in the control
group and the experimental group.
[RR = EER/CER]
56. Relative Benefit
Increase (RBI)
the proportional increase in benefit
between the rates of events in the
control group and the experimental
group.
[RBI = EER - CER / CER]
57. Numbers Needed to
Treat (NNT)
The number of patients who need to be treated
to prevent one bad outcome or produce one
good outcome.
It is the number of patients that a clinician
would have to treat with the experimental
treatment compared to the control treatment
to achieve one additional patient with a
favorable outcome.
[NNT = 1/ARR]
63. Evaluating the Validity of
a Diagnostic Test Study
Statistical questions and concerns
are slightly different
64. Are the results
valid?
1. Did participating patients present
a diagnostic dilemma?
2. Did investigators compare the test
to an appropriate, independent
reference standard?
65. Are the results
valid?
3. Were those interpreting the test and
reference standard blind to the other
results?
4. Did the investigators perform the same
reference standard to all patients
regardless of the results of the test under
investigation?
71. How can I apply the
results to patient care?
Will the reproducibility of the test
result and its interpretation be
satisfactory in your clinical setting?
Are the study results applicable to
the patients in your practice?
72. How can I apply the
results to patient care?
Will the test results change your
management strategy?
Will patients be better off as a result
of the test?